Animal models of toxicology testing: the role of pigs

被引:92
作者
Helke, Kristi L. [1 ]
Swindle, Marvin Michael [1 ]
机构
[1] Med Univ S Carolina, Charleston, SC 29425 USA
关键词
cytochrome P450; drug metabolism; kidney; liver; pig; skin; toxicology; DRUG-METABOLIZING ACTIVITIES; SUS-SCROFA-DOMESTICA; P-GLYCOPROTEIN MDR1; IN-VITRO METABOLISM; LIVER-MICROSOMES; CYTOCHROME-P450; ENZYMES; MINIATURE PIGS; UDP-GLUCURONOSYLTRANSFERASES; XENOBIOTIC METABOLISM; ORAL BIOAVAILABILITY;
D O I
10.1517/17425255.2013.739607
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: In regulatory toxicological testing, both a rodent and non-rodent species are required. Historically, dogs and non-human primates (NHP) have been the species of choice of the non-rodent portion of testing. The pig is an appropriate option for these tests based on metabolic pathways utilized in xenobiotic biotransformation. Areas covered: This review focuses on the Phase I and Phase II biotransformation pathways in humans and pigs and highlights the similarities and differences of these models. This is a growing field and references are sparse. Numerous breeds of pigs are discussed along with specific breed differences in these enzymes that are known. While much available data are presented, it is grossly incomplete and sometimes contradictory based on methods used. Expert opinion: There is no ideal species to use in toxicology. The use of dogs and NHP in xenobiotic testing continues to be the norm. Pigs present a viable and perhaps more reliable model of non-rodent testing.
引用
收藏
页码:127 / 139
页数:13
相关论文
共 50 条
  • [21] Transgenic pigs as models for translational biomedical research
    Aigner, Bernhard
    Renner, Simone
    Kessler, Barbara
    Klymiuk, Nikolai
    Kurome, Mayuko
    Wuensch, Annegret
    Wolf, Eckhard
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2010, 88 (07): : 653 - 664
  • [22] ANIMAL WELL-BEING IN PHARMACOLOGY AND TOXICOLOGY RESEARCH
    HAMMOND, AC
    JOURNAL OF ANIMAL SCIENCE, 1994, 72 (02) : 523 - 527
  • [23] TOXICOLOGY OF SULFITING AGENTS .1. ANIMAL STUDIES
    TIL, HP
    FERON, VJ
    FOOD ADDITIVES AND CONTAMINANTS, 1992, 9 (05): : 587 - 595
  • [24] Liver cell models in in vitro toxicology
    Guillouzo, A
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 : 511 - 532
  • [25] Animal personality in the management and welfare of pigs
    O'Malley, Carly, I
    Turner, Simon P.
    D'Eath, Richard B.
    Steibel, Juan P.
    Bates, Ronald O.
    Ernst, Catherine W.
    Siegford, Janice M.
    APPLIED ANIMAL BEHAVIOUR SCIENCE, 2019, 218
  • [26] Selecting appropriate animal models and experimental designs for endocrine disruptor research and testing studies
    Stokes, WS
    ILAR JOURNAL, 2004, 45 (04) : 387 - 393
  • [27] Alternatives to animal testing
    Fabre, Isabelle
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2009, 193 (08): : 1783 - 1791
  • [28] Pharmacological properties of mifepristone: toxicology and safety in animal and human studies
    Sitruk-Ware, R
    Spitz, IM
    CONTRACEPTION, 2003, 68 (06) : 409 - 420
  • [29] Toxicology research for precautionary decision-making and the role of Human & Experimental Toxicology
    Grandjean, P.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2015, 34 (12) : 1231 - 1237
  • [30] Making in silico predictive models for toxicology FAIR
    Cronin, Mark T. D.
    Belfield, Samuel J.
    Briggs, Katharine A.
    Enoch, Steven J.
    Firman, James W.
    Frericks, Markus
    Garrard, Clare
    Maccallum, Peter H.
    Madden, Judith C.
    Pastor, Manuel
    Sanz, Ferran
    Soininen, Inari
    Sousoni, Despoina
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2023, 140